|
Olivier Charmeil is a graduate of HEC (Ecole des Hautes Etudes Commerciales) and of the Institut d�Etudes Politiques in Paris. From 1989 to 1994 he worked in the Mergers & Acquisitions department of Banque de l�Union Europ�enne. He joined Sanofi Pharma in 1994 as head of Business Development. Subsequently he held various posts within the Group including Chief Financial Officer (Asia) for Sanofi-Synth�labo in 1999 and Attach� to the Chairman Jean-Fran�ois Dehecq in 2000 before being appointed as Vice President Development within the Sanofi-Synth�labo International Operations Directorate where he was responsible for China and support functions. In 2003 Olivier Charmeil was appointed Chairman and Chief Executive Officer of Sanofi-Synth�labo France before taking the post of Senior Vice President Business Management and Support within the Pharmaceutical Operations Directorate. In this role he piloted the operational integration of Sanofi-Synth�labo and Aventis. He was appointed to his current position in February 2006.
| 